• Home
  • Study Materials
    • BCPS Study Material Options
    • BCGP Study Material Options
    • BCACP Study Material Options
    • BCMTMS Study Material Options
    • NAPLEX Study Material
  • Resources
    • Amazon Books
    • Audiobooks
    • Professional Development
    • Free Webinar
  • Blog
  • Podcast
  • Contact
  • My Account
Avoid NSAIDs in COVID-19? Where’s the Evidence?

Avoid NSAIDs in COVID-19? Where’s the Evidence?

by Eric Christianson | Mar 18, 2020 | Clinical Pharmacy News and New Drug Updates

I’m seeing this article all over the place recommending to avoid NSAIDs in patients who have an infection with the new COVID-19 coronavirus. My question is, where’s the evidence? The only thing I can find is that it was based upon is a scientific theory as...
Top 5 Beers Criteria Updates 2019

Top 5 Beers Criteria Updates 2019

by Eric Christianson | Sep 15, 2019 | Clinical Guideline Updates For Pharmacists

The Beers Criteria was updated in 2019. Of the numerous updates, I wanted to pull out my top 5 clinically relevant Beers Criteria updates. It is important to note that there were many more updates, but I wanted to share some of the most clinically important updates....
Comparing Lorazepam and Diazepam

Comparing Lorazepam and Diazepam

by Eric Christianson | Sep 1, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls

Benzodiazepines are on the Beers criteria. They can have significant adverse effects like sedation, confusion, the risk for dependence, and increased fall risk. We like to avoid benzodiazepines if we can, but what if we do feel that it is necessary (i.e. hospice or...
Medication in Parkinson’s

Medication in Parkinson’s

by Eric Christianson | May 8, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls

Parkinson’s is one of the most complex disease states you will encounter. Whenever you talk about a disease of the brain and nervous system, you know that we likely don’t have a 100% clear understanding of how it works and why it happens. However, we...

Orthostasis Risk with SGLT-2 Inhibitors

by Eric Christianson | Dec 26, 2018 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists

Orthostasis risk with SGLT-2 Inhibitors is a potential minor concern, particularly in our geriatric population.  While a drop in blood pressure can be a good thing for a significant chunk of diabetes patients, that potential modest drop can lead to an increased...
« Older Entries

Buy on Amazon

Free 18 Page PDF On The Most Notable Drug Interactions!

CLICK HERE, subscribe now, and get a free PDF on my TOP Drug Interactions in clinical practice!

Looking for something?

Recent Posts

  • Do Combination Pills Improve Adherence? How Much?
  • PPI Failure in GERD? Now What?
  • Nitrate Tolerance Prevention – Clinical Pharmacy Principles
  • 150+ Page Paperback MPJE Book For Less Than 5$ – Ending Soon!
  • Ciprofloxacin And Zolpidem Interaction – Case Study

Categories

Subscribe to the Blog

Enjoy the blog? Over 6,000 pharmacy loving folks follow the blog, why aren’t you? Subscribe now and get a free gift as well!

Success!

Subscribe

NAVIGATION

  • Home
  • Contact
  • About
  • Terms of Service
  • Privacy Policy

Subscribe to the Blog!

Enjoy the blog?  Over 6,000 pharmacy loving folks follow the blog, why aren't you? Subscribe now and get a free gift as well!

Recent Posts

  • Do Combination Pills Improve Adherence? How Much?
  • PPI Failure in GERD? Now What?
  • Nitrate Tolerance Prevention – Clinical Pharmacy Principles
  • 150+ Page Paperback MPJE Book For Less Than 5$ – Ending Soon!
  • Ciprofloxacin And Zolpidem Interaction – Case Study

Copyright 2022 –  MEDED101.COM